Therapeutic compounds

Details for Australian Patent Application No. 2009217551 (hide)

Owner Merck Sharp & Dohme Corp. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.

Inventors McIntyre, Charles A.; Rudd, Michael T.; Liverton, Nigel J.; Harper, Steven; McCauley, John A.

Agent Spruson & Ferguson

Pub. Number AU-A-2009217551

PCT Pub. Number WO2009/108507

Priority 61/067,012 25.02.08 US

Filing date 12 February 2009

Wipo publication date 3 September 2009

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/108507 Priority application(s): WO2009/108507

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.; Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217554-Polyurethane elastomer articles from low free diphenylmethane diisocyanate prepolymers

2009217546-Atrial defibrillation using an implantable defibrillation system